- Introducción al problema de la continuidad del tratamiento beneficioso para los sujetos de investigación.Ignacio Mastroleo - 2015 - In Jorge Alberto Álvarez Díaz (ed.), Ensayos sobre ética de la salud. Universidad Autónoma Metropolitana - Unidad Xochimilco. pp. 67 - 99.details
|
|
International Clinical Research and Justice in the Belmont Report.Joseph Millum - 2020 - Perspectives in Biology and Medicine 63 (2):374-388.details
|
|
Incidental Findings in Low‐Resource Settings.Haley K. Sullivan & Benjamin E. Berkman - 2018 - Hastings Center Report 48 (3):20-28.details
|
|
Implementing post-trial access plans for HIV prevention research.Amy Paul, Maria W. Merritt & Jeremy Sugarman - 2018 - Journal of Medical Ethics 44 (5):354-358.details
|
|
Modelo de reciprocidad democrática: una justificación de la continuidad de tratamiento beneficioso en la investigación clínica.Ignacio Mastroleo - 2016 - Journal of Science Humanities and Arts 3 (7):1-33.details
|
|
MRCT Center Post-Trial Responsibilities Framework Continued Access to Investigational Medicines. Guidance Document. Version 1.0, December 2016.Carmen Aldinger, Barbara Bierer, Rebecca Li, Luann Van Campen, Mark Barnes, Eileen Bedell, Amanda Brown-Inz, Robin Gibbs, Deborah Henderson, Christopher Kabacinski, Laurie Letvak, Susan Manoff, Ignacio Mastroleo, Ellie Okada, Usharani Pingali, Wasana Prasitsuebsai, Hans Spiegel, Daniel Wang, Susan Briggs Watson & Marc Wilenzik - 2016 - The Multi-Regional Clinical Trials Center of the Brigham and Women’s Hospital and Harvard (MRCT Center).details
|
|
Introduction: Case Studies in the Ethics of Mental Health Research.J. Millum - 2012 - Journal of Nervous and Mental Disease 200:230-35.details
|
|
Post‐trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation.Ignacio Mastroleo - 2016 - Developing World Bioethics 16 (2):80-90.details
|
|
La obligación de continuidad de tratamiento beneficioso hacia los sujetos de investigación.Ignacio Mastroleo - 2012 - Dissertation, Universidad de Buenos Airesdetails
|
|
Mind the gap: An empirical study of post‐trial access in HIV biomedical prevention trials.Bridget Haire & Christopher Jordens - 2013 - Developing World Bioethics 15 (2):85-97.details
|
|
Philosophical expertise beyond intuitions.Anna Drożdżowicz - 2017 - Philosophical Psychology 31 (2):253-277.details
|
|
Formulating an Ethics of Pharmaceutical Disinvestment.Jessica Pace, Tracey-Lea Laba, Marie-Paul Nisingizwe & Wendy Lipworth - 2020 - Journal of Bioethical Inquiry 17 (1):75-86.details
|
|
Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.J. Lawton, M. Blackburn, D. Rankin, C. Werner, C. Farrington, R. Hovorka & N. Hallowell - 2019 - AJOB Empirical Bioethics 10 (2):100-112.details
|
|
What is good medical ethics? A clinician's perspective.Wing May Kong - 2015 - Journal of Medical Ethics 41 (1):79-82.details
|
|
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, David Nutt & Meg J. Spriggs - 2023 - Neuroethics 17 (1):1-17.details
|
|
Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research.Sonia M. Dainesi & Moises Goldbaum - 2012 - Journal of Medical Ethics 38 (12):757-762.details
|
|
Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.Pamela Andanda & Jane Wathuta - 2018 - Medicine, Health Care and Philosophy 21 (1):139-155.details
|
|